Search research articles

Search research articles

Related Experiment Videos

Ribavirin effect on experimental Junin virus-induced encephalitis.

M C Remesar¹, J L Blejer, M C Weissenbacher

¹Departamento de Microbiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina.

Journal of Medical Virology

|September 1, 1988

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trans-sialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina.

Vox sanguinis·2009

Same author

Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.

Journal of viral hepatitis·2008

Same author

Long-lasting astrocyte reaction to persistent Junin virus infection of rat cortical neurons.

Journal of neural transmission (Vienna, Austria : 1996)·2003

Same author

Antibodies to Trypanosoma cruzi among blood donors in Buenos Aires, Argentina.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2001

Same author

[Is TT virus (TTV) a true hepatitis virus cause?].

Medicina·2001

Same author

Transmission of HTLV-I by kidney transplant.

Transfusion·2000

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ribavirin demonstrated protective effects against Junin virus-induced encephalitis in rat models. This antiviral agent significantly reduced mortality and neuropathology, supporting its potential for Argentine hemorrhagic fever treatment.

Area of Science:

Virology
Neuroscience
Pharmacology

Background:

Junin virus causes Argentine hemorrhagic fever, a disease with significant mortality and neurological complications.
Experimental models in young rats are susceptible to Junin virus, developing severe encephalitis and high mortality.

Purpose of the Study:

To evaluate the efficacy of Ribavirin in protecting against Junin virus-induced neuropathology in rat models.
To assess Ribavirin's impact on survival rates and viral replication in the central nervous system.

Main Methods:

Intracerebral inoculation of 10-day-old rats with Junin virus, followed by Ribavirin administration.
Intraperitoneal inoculation of 2-day-old rats with Junin virus, with daily Ribavirin treatment.
Assessment of mortality, survival rates, and viral titers in the central nervous system.

Related Experiment Videos

Main Results:

Ribavirin administration before intracerebral infection provided up to 40% protection in 10-day-old rats.
Daily Ribavirin treatment resulted in 73% survival in intraperitoneally infected 2-day-old rats.
Ribavirin significantly reduced viral replication in peritoneal macrophages and lowered central nervous system viral loads.

Conclusions:

Ribavirin exhibits protective effects against Junin virus-induced neuropathology and mortality in experimental rat models.
The antiviral activity of Ribavirin involves reducing viral replication and subsequent spread to the central nervous system.
These findings warrant further investigation of Ribavirin for potential human clinical trials in treating Argentine hemorrhagic fever.